Century Therapeutics Inc (NASDAQ: IPSC) is -50.90% lower on its value in year-to-date trading and has touched a low of $1.14 and a high of $5.51 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IPSC stock was last observed hovering at around $1.35 in the last trading session, with the day’s gains setting it 0.28%.
Currently trading at $1.63, the stock is 23.02% and 12.90% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing 20.74% at the moment leaves the stock -37.47% off its SMA200. IPSC registered 11.64% gain for a year compared to 6-month loss of -47.08%. The firm has a 50-day simple moving average (SMA 50) of $1.4437 and a 200-day simple moving average (SMA200) of $2.606625.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 19.85% gain in the last 1 month and extending the period to 3 months gives it a -5.78%, and is 29.37% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.69% over the week and 10.71% over the month.
Century Therapeutics Inc (IPSC) has around 165 employees, a market worth around $167.35M and $2.69M in sales. Profit margin for the company is -4837.73%. Distance from 52-week low is 42.98% and -70.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.69%).
The EPS is expected to grow by 30.50% this year
102.0 institutions hold shares in Century Therapeutics Inc (IPSC), with institutional investors hold 83.05% of the company’s shares. The shares outstanding are 60.34M, and float is at 34.38M with Short Float at 6.57%. Institutions hold 59.50% of the Float.
The top institutional shareholder in the company is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with over 5.41 million shares valued at $13.8 million. The investor’s holdings represent 8.6848 of the IPSC Shares outstanding. As of 2024-06-30, the second largest holder is VR ADVISER, LLC with 5.39 million shares valued at $13.74 million to account for 8.651 of the shares outstanding. The other top investors are CASDIN CAPITAL, LLC which holds 5.19 million shares representing 8.3319 and valued at over $13.24 million, while BOXER CAPITAL, LLC holds 7.8682 of the shares totaling 4.9 million with a market value of $12.5 million.
Century Therapeutics Inc (IPSC) Insider Activity
The most recent transaction is an insider sale by Farid Adrienne, the company’s Chief Operations Officer. SEC filings show that Farid Adrienne sold 1,033 shares of the company’s common stock on Nov 04 ’24 at a price of $1.23 per share for a total of $1267.0. Following the sale, the insider now owns 0.14 million shares.
Century Therapeutics Inc disclosed in a document filed with the SEC on Nov 04 ’24 that Carr Douglas (SVP Finance & Operations) sold a total of 283 shares of the company’s common stock. The trade occurred on Nov 04 ’24 and was made at $1.23 per share for $347.0. Following the transaction, the insider now directly holds 0.32 million shares of the IPSC stock.
Still, SEC filings show that on Nov 04 ’24, Farid Adrienne (Officer) Proposed Sale 1,033 shares at an average price of $1.23 for $1268.0. The insider now directly holds shares of Century Therapeutics Inc (IPSC).
